Horizon Therapeutics Selected to Present at InsideVenture's Debut Investor Conference March 25-26, Santa Barbara, ... ( SANTA BARBARA Calif. March 23 /- Hori...)

HOME >> BIOLOGY >> TECHNOLOGY

Horizon Therapeutics Selected to Present at InsideVenture's Debut Investor Conference March 25-26, Santa Barbara, California

Date:3/23/2009

SANTA BARBARA, Calif., March 23 /PRNewswire/ -- Horizon Therapeutics, a privately held biopharmaceutical company today announced that Tim Walbert, president and chief executive officer will present at InsideVenture's Debut Conference, March 25-26, 2009 in Santa Barbara, California. Horizon Therapeutics has been selected from over 170 nominations to be one of 50 top private companies showcased to long-term investors through presentations and 1-on-1 meetings at the invitation only conference. Mr. Walbert will provide an update on the status and upcoming milestones in the development and commercialization of its lead product, HZT-501, a combination high dose ibuprofen and famotidine (Pepcid(R)), including completion and filing of a new drug application later this year. InsideVenture's Selection Boards includes Founders and Partners of leading venture firms including NEA, Venrock, DCM, Domain, Frazier, Clarus, Oak Investment, Aisling, and Versant. Over 130 investors are represented in the selected companies.

"We are honored to support Horizon in their private funding efforts through our online platform and at our debut transactional conference in Santa Barbara," said Mona DeFrawi, Chief Executive Officer of InsideVenture. "InsideVenture was created as a powerful and cost-effective platform to support the companies that grow our economy by facilitating their late stage and pre-IPO financing needs. Structural changes in the capital markets over the past 10 years have blocked the real path to economic growth by challenging the financing of the companies delivering valuable new products, jobs and profits for the world economy. These top 50 companies have invested in innovation, and now InsideVenture is innovating the investment process to support their continued growth"

"Horizon Therapeutics is pleased to use InsideVenture's new financing platform because it provides an efficient means to access and build relationships with a numb
'/>"/>

0

GOOD

Page: 1 2 3
Related biology technology :

1. Horizon Therapeutics Announces Senior Management Appointments
2. Horizon Therapeutics Names Robert J. De Vaere Executive Vice President and Chief Financial Officer
3. Horizon Therapeutics to Present at JMP Securities Healthcare Focus Conference
4. Horizon Therapeutics to Present at UBS Global Life Sciences Conference
5. Horizon Therapeutics Announces Corporate Relocation to the Chicago Area
6. BioHorizons Global Symposium 2008 Combines Record Attendance with Groundbreaking Technology
7. BioHorizons Announces the Purchase of Implant Logic Systems
8. Caliper Life Sciences Forms Alliance With Horizon Discovery to Provide Enhanced Solutions for Cancer Research Based on Isogenic Cell Lines
9. Biotech Pioneer William J. Rutter to Deliver Keynote at 2008 RAPS Horizons Conference
10. BioHorizons Announces Agreement to Purchase Implant Logic Systems
11. Out beyond the horizon

Post Your Comments:

Horizon Therapeutics Selected to Present at InsideVenture's Debut Investor Conference March 25-26, Santa Barbara, ...( SANTA BARBARA Calif. March 23 /- Hori...)